Choice Hotels International
CHH
103.49
+0.43
+0.42%
Choice Hotels International
US · CHH
#2211 by market cap
Listed 1970
103.49
+0.43
+0.42%
Live - 5344 symbols - heartbeat 367s ago
· 2026-10-07 20:02
After-hours
103.49
0.00%
- Market cap
- 4.66B
- P/E (TTM)i
- 14.66
- P/Bi
- 32.76
- EPSi
- 7.90
- Div yieldi
- 1.11%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on CHH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.17, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.75% YoY
Margins
- Gross margin
- 52.72%
- Operating margin
- 28.38%
- Net margin
- 23.06%
Key ratios & quality
- Enterprise valuei
- 6.53B
- PEG ratioi
- 4.01
- Altman Z-Scorei
- 3.17
PEG uses trailing P/E against the 3-year net income growth rate (3.66%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.04B | 1.11B | 774.07M | 1.07B | 1.40B | 1.54B | 1.58B | 1.60B |
| Gross profit | 507.04M | 521.23M | 311.16M | 599.60M | 700.05M | 792.28M | 845.35M | 841.77M |
| Selling & admin expenses | 170.03M | 168.94M | 148.91M | 145.62M | 167.70M | 312.70M | 312.39M | 328.96M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 322.68M | 333.47M | 136.42M | 429.20M | 501.93M | 434.54M | 481.01M | 453.10M |
| Pretax profit | 273.26M | 269.93M | 53.01M | 376.49M | 436.81M | 336.96M | 395.65M | 456.89M |
| Tax | 56.90M | 47.05M | -22.38M | 87.54M | 104.65M | 78.45M | 95.98M | 86.95M |
| Net profit | 216.36M | 222.88M | 75.39M | 288.96M | 332.15M | 258.51M | 299.67M | 369.95M |
| Basic EPS | 4 | 4 | 1 | 5 | 6 | 5 | 6 | 8 |
| Diluted EPS | 3.80 | 3.98 | 1.35 | 5.15 | 5.99 | 5.07 | 6.20 | 7.90 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 332.86M | 426.44M | 447.34M | 390.15M | 340.58M | 440.76M |
| Gross profit | 167.99M | 227.67M | 239.28M | 206.84M | 155.14M | 217.64M |
| Selling & admin expenses | 74.21M | 89.30M | 79.61M | 85.84M | 78.05M | 96.15M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 80.03M | 124.94M | 143.91M | 104.22M | 60.27M | 104.67M |
| Pretax profit | 59.76M | 108.61M | 210.92M | 77.60M | 30.31M | 85.88M |
| Tax | 15.23M | 26.88M | 30.92M | 13.92M | 10.01M | 21.54M |
| Net profit | 44.53M | 81.73M | 180.00M | 63.68M | 20.30M | 64.34M |
| Basic EPS | 1 | 2 | 4 | 1 | 0 | 1 |
| Diluted EPS | 0.94 | 1.75 | 3.86 | 1.37 | 0.44 | 1.41 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 243.78M | 236.59M | 432.91M | 761.66M | 347.92M | 296.53M | 339.09M | 406.00M |
| Cash & ST investments | 26.64M | 33.77M | 234.78M | 511.61M | 41.57M | 26.75M | 40.18M | 45.00M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.14B | 1.39B | 1.59B | 1.93B | 2.10B | 2.39B | 2.53B | 2.92B |
| Total current liabilities | 318.44M | 325.89M | 255.85M | 570.30M | 435.90M | 942.69M | 462.72M | 467.29M |
| Short-term debt | 1.10M | 17.61M | 10.60M | 228.35M | 13.64M | 503.51M | 5.37M | 8.36M |
| Long-term debt | 753.51M | 844.10M | 1.06B | 844.12M | 1.20B | 1.07B | 1.77B | 1.91B |
| Total liabilities | 1,322,142,000.00 | 1,410,183,000.00 | 1,593,085,000.00 | 1,665,942,000.00 | 1,947,515,000.00 | 2,359,201,000.00 | 2,575,798,000.00 | 2,736,974,000.00 |
| Total equity | -183.77M | -23.51M | -5.75M | 265.88M | 154.66M | 35.60M | -45.27M | 181.23M |
| Retained earnings | 795.18M | 968.83M | 1.02B | 1.28B | 1.56B | 1.76B | 2.00B | 2.32B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 358.20M | 400.68M | 450.35M | 406.00M | 410.78M | 431.94M |
| Cash & ST investments | 40.05M | 58.61M | 52.58M | 45.00M | 43.87M | 42.83M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.58B | 2.66B | 2.91B | 2.92B | 2.94B | 2.99B |
| Total current liabilities | 427.42M | 451.93M | 468.54M | 467.29M | 433.99M | 466.47M |
| Short-term debt | -- | -- | -- | 8.36M | -- | -- |
| Long-term debt | 1.87B | 1.90B | 1.92B | 1.91B | 2.00B | 2.00B |
| Total liabilities | 2,641,522,000.00 | 2,691,000,000.00 | 2,757,760,000.00 | 2,736,974,000.00 | 2,807,159,000.00 | 2,846,638,000.00 |
| Total equity | -63.93M | -26.24M | 149.77M | 181.23M | 137.43M | 142.18M |
| Retained earnings | 2.03B | 2.10B | 2.27B | 2.32B | 2.33B | 2.38B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 242.90M | 270.56M | 110.06M | 383.70M | 367.06M | 296.55M | 319.40M | 270.45M |
| Depreciation & amortization | 33.93M | 36.12M | 48.46M | 50.49M | 63.91M | 75.74M | 70.86M | 79.27M |
| Free cash flow | 193.42M | 206.52M | 75.10M | 305.83M | 277.11M | 180.28M | 173.55M | 124.65M |
| Dividends paid | -48.72M | -48.09M | -25.27M | -25.04M | -52.55M | -56.46M | -55.50M | -53.47M |
| Stock buybacks / issuance | -148.68M | -50.64M | -55.45M | -13.37M | -434.77M | -362.77M | -380.74M | -138.30M |
| Ending cash balance | 26.64M | 33.77M | 234.78M | 511.61M | 41.57M | 26.75M | 40.18M | 45.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 20.47M | 95.60M | 68.69M | 85.69M | -23.17M | 90.54M |
| Depreciation & amortization | 18.64M | 17.96M | 20.63M | 22.04M | 21.94M | 22.93M |
| Free cash flow | -25.54M | 57.60M | 40.46M | 52.13M | -50.06M | 72.23M |
| Dividends paid | -13.47M | -13.40M | -13.33M | -13.28M | -13.12M | -13.22M |
| Stock buybacks / issuance | -64.62M | -48.13M | -202.00K | -25.35M | -56.48M | -50.98M |
| Ending cash balance | 40.05M | 58.61M | 52.58M | 45.00M | 43.87M | 42.83M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | 221.30 | 157.07 | 270.29 | -- | 541.59 |
| ROA %i | 20.82 | 17.55 | 5.04 | 16.36 | 16.37 | 11.44 | 12.11 | 13.51 |
| ROIC %i | -- | -- | -- | 26.11 | 25.45 | 19.01 | -- | 21.60 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 30.65 | 28.41 | 13.18 | 39.57 | 34.28 | 25.95 | 30.46 | 34.32 |
| FCF / sales %i | 18.57 | 18.52 | 9.70 | 28.60 | 19.51 | 11.54 | 10.95 | 7.81 |
| Current ratioi | 0.77 | 0.73 | 1.69 | 1.34 | 0.80 | 0.31 | 0.73 | 0.87 |
| Quick ratioi | 0.66 | 0.65 | 1.61 | 1.28 | 0.72 | 0.27 | 0.64 | 0.77 |
| Debt / assetsi | 66.29 | 63.68 | 68.17 | 57.35 | 61.14 | 70.22 | 74.58 | 69.30 |
| LT debt / equityi | -- | -- | -- | 330.83 | 822.15 | 3,309.83 | -- | 1,111.35 |
| Interest coveragei | 6.95 | 6.77 | 2.08 | 9.07 | 10.97 | 6.28 | 5.54 | 6.01 |
| Revenue CAGR (3Y) %i | 6.59 | 11.33 | -6.31 | 0.89 | 7.94 | 25.88 | 14.02 | 4.43 |
| Net income CAGR (3Y) %i | 19.11 | 27.83 | -14.90 | 10.13 | 14.22 | 50.80 | 1.22 | 3.66 |
| FCF CAGR (3Y) %i | 12.30 | 18.45 | -31.28 | 16.50 | 10.30 | 33.90 | -17.21 | -23.38 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | 1,418.09 | 541.59 | 936.35 | 563.78 |
| ROA %i | 12.33 | 11.82 | 13.95 | 13.51 | 12.46 | 11.56 |
| ROIC %i | -- | -- | 22.25 | 21.60 | 19.91 | 18.88 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 31.74 | 31.34 | 35.68 | 34.32 | 32.49 | 30.89 |
| FCF / sales %i | 11.29 | 10.50 | 7.79 | 7.81 | 6.24 | 7.09 |
| Current ratioi | 0.84 | 0.89 | 0.96 | 0.87 | 0.95 | 0.93 |
| Quick ratioi | 0.73 | 0.80 | 0.86 | 0.77 | 0.82 | 0.83 |
| Debt / assetsi | 77.09 | 75.48 | 69.76 | 69.30 | 71.64 | 70.49 |
| LT debt / equityi | -- | -- | 1,354.23 | 1,111.35 | 1,535.08 | 1,481.73 |
| Interest coveragei | 5.71 | 5.68 | 6.43 | 6.01 | 5.55 | 5.24 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Hotel Franchising & Management is the largest reported line at 92.49% of revenue, across 3 reported segments.
- The next-largest line, Corporate & Other, is a distant second at 8.33% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Hotel Franchising & Management92.49%
Corporate & Other8.33%
Quote time 2026-10-07 20:02:40 · For reference only, not investment advice and not tailored to your situation.